A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells

  1. Martín-Rodríguez, P.
  2. Guerra, B.
  3. Hueso-Falcón, I.
  4. Aranda-Tavío, H.
  5. Díaz-Chico, J.
  6. Quintana, J.
  7. Estévez, F.
  8. Díaz-Chico, B.
  9. Amesty, A.
  10. Estévez-Braun, A.
  11. Fernández-Pérez, L.
Aldizkaria:
Frontiers in Pharmacology

ISSN: 1663-9812

Argitalpen urtea: 2019

Alea: 9

Zenbakia: JAN

Mota: Artikulua

DOI: 10.3389/FPHAR.2018.01546 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus